Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

47.4K
Overview
47.4K
Cancer Vaccines01:30

Cancer Vaccines

582
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
582
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

893
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
893
Chronopharmacokinetics: Time-Dependent Pharmacokinetics01:20

Chronopharmacokinetics: Time-Dependent Pharmacokinetics

250
Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
250
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

57
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
57
Immunological Memory01:23

Immunological Memory

11.9K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
11.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time to provide clear guidance around respiratory protection for hantavirus during outbreaks involving human to human transmission.

International journal of nursing studies·2026
Same author

Determinants of fatalities and secondary transmission in laboratory pathogen incidents, 1900-2025.

The Journal of infection·2026
Same author

Machine Learning-Based Geospatial Risk Modeling of Global Avian Influenza Outbreaks.

Transboundary and emerging diseases·2026
Same author

Comparison of Artificial Intelligence Tools With Human Coding for Sentiment, Topic, and Thematic Analysis Tasks of Public Health Datasets During the COVID-19 Pandemic in Australia: Case Study.

Online journal of public health informatics·2026
Same author

COVID-19 vaccination and mortality among coronary care patients with severe acute respiratory infection in Bangladesh: a prospective study (2021-2024).

The Lancet regional health. Southeast Asia·2026
Same author

Detection of SARS-CoV-2 in aerosol and surface samples in high acuity hospital settings during community epidemic waves - implications for risk-based infection control.

Respiratory medicine·2026
Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026
Same journal

Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial.

Vaccine·2026
Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026
Same journal

Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.

Vaccine·2026
Same journal

Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.

Vaccine·2026
See all related articles

Related Experiment Video

Updated: Oct 27, 2025

Methodology for the Efficient Generation of Fluorescently Tagged Vaccinia Virus Proteins
09:27

Methodology for the Efficient Generation of Fluorescently Tagged Vaccinia Virus Proteins

Published on: January 17, 2014

7.8K

Vaccinating Australia: How long will it take?

Mark Hanly1, Timothy Churches2, Oisín Fitzgerald1

  • 1Centre for Big Data Research in Health, UNSW Sydney, Australia.

Vaccine
|July 21, 2021
PubMed
Summary
This summary is machine-generated.

Achieving 90% COVID-19 vaccine coverage in Australia by year-end requires administering 200,000 doses daily. Vaccine hesitancy significantly impacts rollout speed, emphasizing the need for public health messaging.

Keywords:
AustraliaCOVID-19Vaccination

More Related Videos

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 1
12:00

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 1

Published on: April 8, 2009

10.5K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.4K

Related Experiment Videos

Last Updated: Oct 27, 2025

Methodology for the Efficient Generation of Fluorescently Tagged Vaccinia Virus Proteins
09:27

Methodology for the Efficient Generation of Fluorescently Tagged Vaccinia Virus Proteins

Published on: January 17, 2014

7.8K
Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 1
12:00

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 1

Published on: April 8, 2009

10.5K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.4K

Area of Science:

  • Epidemiology
  • Public Health
  • Health Policy

Background:

  • The Australian national COVID-19 vaccination program commenced in February 2021.
  • The objective was to vaccinate the adult population by October 2021, facing significant logistical hurdles.
  • Rapid vaccine rollout is critical for border reopening and mitigating risks from transmissible variants.

Purpose of the Study:

  • To project the timeline for Australia's COVID-19 vaccine rollout under various administration rates, eligibility schedules, and vaccine hesitancy levels.
  • To identify key factors influencing the duration of the national vaccination program.
  • To inform public health strategies for achieving timely population immunity.

Main Methods:

  • Utilized projection modeling to simulate vaccination rollout scenarios.
  • Analyzed the impact of daily vaccine administration rates (e.g., 80,000 vs. 200,000 doses/day).
  • Assessed the influence of vaccine hesitancy and eligibility schedules on overall coverage timelines.

Main Results:

  • A daily administration rate of 200,000 doses is projected to achieve 90% population coverage by the end of 2021.
  • A lower rate of 80,000 doses per day could extend the rollout until mid-2023.
  • Vaccine hesitancy emerges as a primary limiting factor, particularly when vaccine supply is abundant.

Conclusions:

  • The rate of vaccine administration is the most crucial determinant of the COVID-19 vaccine rollout duration in Australia.
  • Achieving rapid population coverage necessitates increasing daily vaccine administration to at least 200,000 doses.
  • Public health messaging promoting vaccine willingness, especially among hesitant demographics, is essential for a swift and effective rollout.